¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Muscle wasting and atrophy, NEC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • red muscle
    Àû»ö±ÙÀ°
  • red muscle fiber
    Àû»ö±Ù(À°)¼¶À¯, Àû»ö±Ù(À°)¼¼Æ÷
  • rhomboid major muscle
    Å«¸¶¸§±Ù, ´ë´ÉÇü±Ù
  • rhomboid minor muscle
    ÀÛÀº¸¶¸§±Ù, ¼Ò´ÉÇü±Ù
  • risorius muscle
    ÀÔ²¿¸®´ç±è±Ù, ¼Ò±Ù
  • sartorius muscle
    ³Ò´Ù¸®ºø±Ù, ºÀ°ø±Ù
  • sartorius muscle flap
    ³Ò´Ù¸®ºø±ÙÆÇ, ³ÐÀû´Ù¸®ºø±ÙÆÇ, ºÀ°ø±ÙÆÇ
  • soleus muscle
    °¡Àڹ̱Ù
  • soleus muscle flap
    °¡ÀÚ¹Ì±ÙÆÇ
  • sphincter ani externus muscle
    ¹Ù±ùÇ×¹®Á¶ÀÓ±Ù, ¿ÜÇ×¹®°ý¾à±Ù
  • sphincter muscle
    Á¶ÀÓ±Ù, °ý¾à±Ù
  • sphincter pupillae muscle
    µ¿°øÁ¶ÀÓ±Ù, µ¿°ø°ý¾à±Ù
  • scalene muscle
    ¸ñ°¥ºñ±Ù, »ç°¢±Ù
  • splenius capitis muscle
    ¸Ó¸®³ÎÆÇ±Ù, µÎÆÇ»ó±Ù
  • splenius muscle
    ³ÎÆÇ±Ù, ÆÇ»ó±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • pronator qudratus muscle
    ³×¸ð¾þħ±Ù
  • pronator teres muscle
    ¿ø¾þħ±Ù
  • psoas muscle
    Ç㸮±Ù
  • pterygoid muscle
    ³¯°³±Ù
  • pterygopharyngeus muscle
    ³¯°³ÀεαÙ
  • pubococcygeus muscle
    µÎµ¢²¿¸®±Ù
  • puborectalis muscle
    µÎµ¢°ðâÀÚ±Ù
  • pyramidalis muscle
    ¹è¼¼¸ð±Ù
  • quadratus femoris muscle
    ³Ò´Ù¸®³×¸ð±Ù
  • quadratus lumborum muscle
    Ç㸮³×¸ð±Ù
  • quadratus plantae muscle
    ¹ß¹Ù´Ú³×¸ð±Ù
  • quadriceps femoris muscle
    ³Ò´Ù¸®³×°¥·¡±Ù
  • rectococcygeal muscle
    °ðâÀÚ²¿¸®±Ù
  • rectovesical muscle
    °ðâÀڹ汤±Ù, Á÷À广±¤±Ù
  • rectus muscle
    °ðÀº±Ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • rapid muscle
    ¼Ó±Ù(áÜÐÉ).
  • recession of muscle
    ±Ù ÅðÃà.
  • recession of muscle
    ±ÙÅðÃà(ÐÉ÷Üõî)
  • recession of muscle
    ±ÙÈÄÀü(¼ú)
  • rectococcygeal muscle ³ª musculus rec to co ccy geus
    Á÷Àå¹Ì°ñ±Ù( òÁíóÚ­ÍéÐÉ).
  • rectourethral muscle
    °ðâÀÚ¿äµµ±Ù
  • rectouterine muscle
    °ðâÀÚÀڱñÙ
  • rectovesical muscle
    °ðâÀڹ汤±Ù
  • rectovesical muscle ³ª musculus rectovesicalis
    Á÷À广±¤±Ù(òÁíóÛ¹ÎÍÐÉ ).
  • rectus muscle
    Á÷±Ù(òÁÐÉ).
  • rectus muscle
    Á÷±Ù, °ðÀº±Ù
  • rectus sheath ; vagina muscle recti abdominis
    º¹Á÷±ÙÃÊ(ÜÙòÁÐÉôú).
  • red muscle
    Àû»ö±Ù(îåßäÐÉ).
  • red muscle fiber
    Àû»ö±Ù¼¶À¯(îåßäÐÉàéë«).
  • red muscle fiber
    Àû»ö±ÙÀ°¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõÐÉê× õêñø).
  • spinobulbar muscular atrophy
  • steroid-induced atrophy
    ½ºÅ×·ÎÀ̵å À§Ãà
  • subacute yellow atrophy of liver
    ¾Æ±Þ¼º °£È²»öÀ§Ãà(¡­ÊÜüÜßäê×õê).
  • subacute yellow atrophy of liver
    ¾Æ±Þ¼º °£È²»öÀ§Ãà(¡­ÊÜüÜßäê×õê)
  • subcutaneous atrophy
    ÇÇÇÏÀ§Ãà
  • testicular atrophy
    °íȯÀ§Ãà(ÍÂü¯ê×õê).
  • testicular atrophy
    °íȯÀ§Ãà(ÍÂü¯ê×õê)
  • thenar atrophy
    ¹«Áö±¸À§Ãà(¡­ê×õê).
  • thenar atrophy
    ¹«Áö?ÍÂ?¡­ê×õê)
  • toxic atrophy
    Áßµ¶¼ºÀ§Ãà(ñéÔ¸àõê×õê)
  • traumatic optic atrophy
    ¿Ü»ó½Ã½Å°æÀ§Ãà
  • yellow atrophy
    Ȳ»öÀ§Ãà(¡­ê×õê)
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • alternate hot and cold caloric examination
    ³Ã¿Â±³´ë(¿Âµµ)Àڱذ˻ç(ÕÒè®Îßû»è®öôô§Ð½ËþÞÛ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
CPM circumference of papillary muscle
CTM cardiotachometer; Chlortrimeton; cricothyroid muscle; computed tomographic myelography
DMC demeclocycline; di(p-chlorophenyl)methylcarbinol; direct microscopic count; duration of muscle contr...
DMR depolarizing muscle relaxant; Diploma in Medical Radiology
ECM electronic claims management; embryonic chick muscle; erythema chronicum migrans; experimental cereb...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
PMR Progressive Muscle Relaxation
PASMC Pulmonary artery smooth muscle cell
RASMC Rat aortic smooth muscle cells
RM Respiratory muscle
RMS Respiratory muscle strength
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • muscle re-education
    ±Ù Àç±³À°, ±ÙÀ° ÈÆ·Ã
    ¼Ò¾Æ ¸¶ºñ, ±æ¶û¹Ù·¹ ÁõÈıº µîÀÇ ¸»ÃʽŰæ Àå¾Ö¿¡ µû¸¥ À̿ϼº ¸¶ºñ¿¡ ´ëÇØ¼­ ½ÃÇàµÇ´Â ¿îµ¿¿ä¹ýÀÇ ÀÏÁ¾ÀÌ´Ù. ±Ù ¼öÃàÀÌ °ÅÀÇ ÀÎÁ¤µÇÁö ¾Ê´Â °æ¿ì¿¡´Â ȯÀÚ¸¦ Ÿµ¿ÀûÀ¸·Î ¿òÁ÷¿©¼­ °íÀ¯ °¨°¢°è¸¦ ÀÚ±ØÇÔÀ¸·Î½á ±ÙÀÇ ¼öÃàÀ» ÃËÁø½ÃŰ·Á´Â °ÍÀÌ´Ù. ±Ù ¼öÃàÀÌ ³ªÅ¸³ª´Â °Í¿¡ µû¶ó¼­ ±Ù·Â Áõ°­ ÈÆ·ÃÀ¸·Î ÀÌ¿ëÇÑ´Ù.
  • muscle rehabilitation
    ±ÙÀ° ÀçȰ
  • muscle relaxation
    ±Ù ÀÌ¿Ï, ±Ù À̿Ϲý
    »ý¸®ÀûÀÎ ±ÙÀ°ÀÇ ÀÌ¿ÏÀ¸·Î Á¤½ÅÀû ºÒ¾È, ±äÀåÀ» ¿ÏÈ­ÇÏ´Â ¹æ¹ýÀÌ´Ù. °¢ ±ÙÀ°±ºÀÇ ÀÌ¿Ï »óÅÂ¿Í ±äÀå »óŸ¦ ºñ±³½ÃŰ¸é¼­ ȯÀÚ°¡ ±×°ÍÀ» °¨ÁöÇϰí ȹµæÇÒ ¼ö ÀÖµµ·Ï ÈÆ·ÃÇÏ´Â °ÍÀ̰í ÀÌ¿¡ µû¶ó¼­ ÀÚÀ²½Å°æÀÇ ¹ë·±½º°¡ ¾ÈÁ¤µÇ¾î ½É½ÅÀÇ Æí¾ÈÇÑ »óŸ¦ ¾òÀ» ¼ö ÀÖ´Ù.
  • muscle relaxation splint
    ±Ù ÀÌ¿Ï ±³ÇÕ ÀåÄ¡, ±ÙÀ° ÀÌ¿Ï ÀåÄ¡
  • muscle rigidity
    ±Ù °­Á÷
  • muscle sclerosis
    ±Ù °æÈ­Áõ
  • muscle setting
    ±Ù ¼¼ÆÃ
    ±ÙÀÇ ±æÀ̸¦ º¯È­½ÃÅ´ ¾øÀÌ ±ÙÀ» ¼öÃà½ÃŰ´Â µîô ¼öÃà ¿îµ¿À̰í ÅëÁõ ¶§¹®¿¡ °üÀýÀÇ ¿òÁ÷ÀÓÀÌ Á¦Çѵǰųª ¼®°íºØ´ë¿¡ ÀÇÇØ °üÀýÀÌ °íÁ¤µÇ°í ÀÖ´Â °æ¿ì µî¿¡ ±ÙÀÇ À§ÃàÀ̳ª ±Ù·Â ÀúÇϸ¦ ¿¹¹æÇϱâ À§ÇØ ½ÃÇàµÈ´Ù. ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î¼­ ´ëÅð»çµÎ±Ù ¼¼ÆÃ ÈÆ·ÃÀÌ ÀÖ´Ù. À̰ÍÀº ¹«¸­À» »¸Àº ÀÚ¼¼ ±×´ë·Î ½½°³°ñÀ» ÁßÃß¹æÇâÀ¸·Î ²ø¾î¿Ã¸®´Â ÈÆ·ÃÀÌ´Ù. ÀÌ¿¡ µû¶ó¼­ ½½°³°ñÀº ÁßÃß¹æÇâÀ¸·Î ¾à cmÁ¤µµ ¿Ã¶ó°¡°í ´ëÅð»çµÎ±ÙÀÇ ÆØÀ²À» º¼ ¼ö ÀÖ´Ù.
  • muscle spasticity
    ±Ù °æ·Ã¼º
  • muscle splinting
    ±ÙÀ° º¸Á¤, º¸È£¼º ±Ù±äÀå
    µ¿ÀǾî=
  • muscle splitting incision
    ±Ù ºÐ¿­ Àý°³, ±Ù¿­ Àý°³).

    muscle stimulant (±Ù ÈïºÐ ¾à, ±Ù ÈïºÐÁ¦

  • muscle stretch reflex
    ±Ù½ÅÀü ¹Ý»ç
  • muscle tenderness
    ±Ù ¾ÐÅë, ±ÙÀ° ¾ÐÅë
  • muscle tension type headache
    ±Ù ±äÀ强 µÎÅë
    ÈĵκÎ, Ç׺ÎÀÇ Áö¼ÓÀûÀÎ ¾Ð¹Ú°¨, ±³¾×°¨À» È£¼ÒÇÑ´Ù. ÀÌ ÁõÀÇ È¯ÀÚ´Â ½Å°æÁú·Î ±äÀåÇϱ⠽¬¿î »ç¶÷¿¡°Ô ¸¹°í °³Ã¼ÀÇ ±Ù±äÀ强¼ÒÀΰú ¾î¿ï¾îÁ® ±ÙÀÇ Áö¼ÓÀû ¼öÃà°ú ±ÙÀÇ ¼øÈ¯ ºÎÀü ¡æ ÅëÁõ ¹°Áú ¹ß»ý ¡æ ÅëÁõ ¡æ ±Ù ¼öÃàÀ̶ó´Â ¾Ç¼øÈ¯ÀÌ Çü¼ºµÇ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù. Á÷¾÷¿¡ µû¸¥ ºÎÀÚ¿¬½º·¯¿î ÀÚ¼¼°¡ °ü·ÃÀÌ ÀÖ´Â °æ¿ìµµ ¸¹°í ½Åü, ½É¸®Àû ¾çÃø¸éÀ¸·ÎºÎÅÍÀÇ Á¢±ÙÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹´Ù.
  • muscle tissue
    ±ÙÀ° Á¶Á÷, ±Ù Á¶Á÷
  • muscle tonus
    ±Ù ±äÀå, »ý¸®Àû ±Ù ±äÀå
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
health care economics and organizations The economic aspects of health care, its planning, and delivery. It includes government agencies and organizations in the private sector.
(12 Dec 1998)
health care facilities, manpower, and services The services provided in the delivery of health care, associated facilities in health care, and attendant manpower required or available.
(12 Dec 1998)
health care quality, access, and evaluation The concept concerned with all aspects of the quality, accessibility, and appraisal of health care and health care delivery.
(12 Dec 1998)
primary hyperoxaluria and oxalosis A metabolic disorder characterised by calcium oxalate nephrocalcinosis and nephrolithiasis, extrarenal oxalosis, and increased urinary output of oxalic and glycolic acids; usually evident clinically in the first decade of life, with progressive renal failure and uraemia; autosomal recessive inheritance. Type I is due to an alteration in alanine:glyoxylate aminotransferase; type II is due to an alteration in d-glycerate dehydrogenase.
(05 Mar 2000)
health services needs and demand Health services required by a population or community as well as the health services that the population or community is able and willing to pay for. It includes the identification and assessment of the needs as measured by objective criteria and standards.
(12 Dec 1998)
heart and lung transplant A surgical procedure which replaces a diseased heart and lungs with a healthy heart and lungs from a donor. They have been used in patients with primary pulmonary hypertension and isolated severe heart and lung disease. They are not recommended for those with associated systemic disorders such as diabetes or autoimmune illness. Those with liver and/or kidney disease are also not candidates. Long-term outcomes are still being studied.
(27 Sep 1997)
saint kitts and nevis An independent federation of the leeward islands in the west indies, consisting of saint christopher, nevis, and sombrero. Its capital is basseterre. It was discovered by columbus in 1493, settled by the british in 1625, the first of the leeward islands to be colonised by them. It was held jointly by the french and english 1628-1713, but returned to great britain by the treaty of utrecht in 1713. It was held by the french 1782-83. Under the british for the next 200 years, it gained its independence in 1983.
(12 Dec 1998)
saint vincent and the grenadines A self-governing state of the windward islands in the west indies, comprising saint vincent and the northern islets of the grenadines. Its capital is kingstown. It is one of the original homes of the carib indians supposed to have been sighted by columbus in 1498. It was in english hands from 1627 till held by the french 1779-83. Saint vincent subsequently became a british possession and, with other nearby british territories, was administered by the governor of the windward islands till 1959. It attained a measure of independence in 1969 but achieved full independence as saint vincent and the grenadines in 1979. Saint vincent was the 4th century spanish martyr on whose feast day columbus discovered the island. Grenadines is derived from the spanish kingdom of granada.
(12 Dec 1998)
salaries and fringe benefits The remuneration paid or benefits granted to an employee.
(12 Dec 1998)
hemic and immune systems The organs involved in the production and functions of the blood and the cellular and molecular components providing defense against foreign organisms or substances.
(12 Dec 1998)
hemic and lymphatic diseases Haematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., erythrocyte aggregation, intravascular) and chemical components (e.g., blood protein disorders); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes.
(12 Dec 1998)
hepatitis d, e, f, and g Lesser known (than hepatitis a, b, and c), the most significant of these seems to be type d, or the delta agent, which only causes disease in the presence of the hepatitis b virus.
(12 Dec 1998)
hereditary deafness and nephropathy <nephrology, pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon.
Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision.
Inheritance: sex-linked autosomal dominant.
Incidence: 1 in 50,000.
Origin: Gr. Pathos = disease
(27 Sep 1997)
prostheses and implants Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. Implants, experimental is available for those used experimentally.
(12 Dec 1998)
prothrombin and proconvertin test A test formerly used by some to control anticoagulant therapy with bishydroxycoumarin and indandione drugs.
Synonym: P and P test.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á